Recombinant multi-species SAMSN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SAMSN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
SAMSN1 is a member of a novel gene family of putative adaptors and scaffold proteins containing SH3 and SAM (sterile alpha motif) domains (Claudio et al., 2001 [PubMed 11536050]).[supplied by OMIM, Mar 2008]
The Alternative Names of target: HACS1,Hematopoietic adaptor containing SH3 and SAM domains 1,NASH1,Nash,Nash1,SAM domain,SAM domain-containing protein SAMSN-1,SAMSN1,SASH2,SH3 domain and nuclear localization signals protein 1,SH3-SAM adaptor protein,SH3D6B,SLy2,Samsn1

Target products collectionGo to SAMSN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2726-Ag-1/ GM-Tg-hg-IP2726-Ag-2 Human SAMSN1 protein Human
GM-Tg-rg-IP2726-Ag-1/ GM-Tg-rg-IP2726-Ag-2 Rat SAMSN1 protein Rat
GM-Tg-mg-IP2726-Ag-1/ GM-Tg-mg-IP2726-Ag-2 Mouse SAMSN1 protein Mouse
GM-Tg-cynog-IP2726-Ag-1/ GM-Tg-cynog-IP2726-Ag-2 Cynomolgus/Rhesus macaque SAMSN1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2726-Ag-1/ GM-Tg-felg-IP2726-Ag-2 Feline SAMSN1 protein Feline
GM-Tg-cang-IP2726-Ag-1/ GM-Tg-cang-IP2726-Ag-2 Canine SAMSN1 protein Canine
GM-Tg-bovg-IP2726-Ag-1/ GM-Tg-bovg-IP2726-Ag-2 Bovine SAMSN1 protein Bovine
GM-Tg-equg-IP2726-Ag-1/ GM-Tg-equg-IP2726-Ag-2 Equine SAMSN1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2726-Ag-1/ GM-Tg-hg-IP2726-Ag-2; GM-Tg-rg-IP2726-Ag-1/ GM-Tg-rg-IP2726-Ag-2;
GM-Tg-mg-IP2726-Ag-1/ GM-Tg-mg-IP2726-Ag-2; GM-Tg-cynog-IP2726-Ag-1/ GM-Tg-cynog-IP2726-Ag-2;
GM-Tg-felg-IP2726-Ag-1/ GM-Tg-felg-IP2726-Ag-2; GM-Tg-cang-IP2726-Ag-1/ GM-Tg-cang-IP2726-Ag-2;
GM-Tg-bovg-IP2726-Ag-1/ GM-Tg-bovg-IP2726-Ag-2; GM-Tg-equg-IP2726-Ag-1/ GM-Tg-equg-IP2726-Ag-2
Products Name SAMSN1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SAMSN1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SAMSN1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.